Table 4 KEGG pathways.

From: Network pharmacology combined with molecular docking and experimental verification to elucidate the effect of flavan-3-ols and aromatic resin on anxiety

Description

Count in gene set

False discovery rate

Bladder cancer

18

2.28 × 10–14

Nicotine addiction

17

2.20 × 10–13

EGFR tyrosine kinase inhibitor resistance

31

4.19 × 10–22

Prolactin signaling pathway

23

7.31 × 10–15

Prostate cancer

31

2.85 × 10–19

Amphetamine addiction

22

5.12 × 10–14

Neuroactive ligand-receptor interaction

111

1.62 × 10–68

Long-term depression

19

2.89 × 10–12

Dopaminergic synapse

28

7.58 × 10–13

Serotonergic synapse

33

2.85 × 10–19

Back to article page